# ClinicalTrials.gov record NCT06424106

> PeptideScanner retained ClinicalTrials.gov record NCT06424106 at 2026-07-30T16:20:49.305Z. Its registry update date was 2026-04-20, and PeptideScanner's reviewed identity mapping was glucagon.

- Evidence object: `story:clinicaltrials-gov-nct06424106-glucagon:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-04-20
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06424106-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06424106-glucagon-v1.json
- Content SHA-256: `c6dc3eaca947a3569da9725b54d4988a8fbcb1121e2f23929319e4cd0e5fa6eb`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06424106 ([`ctg-observation-nct06424106-2026-04-20-90ca90ccbc24`](#source-ctg-observation-nct06424106-2026-04-20-90ca90ccbc24))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06424106 at 2026-07-30T16:20:49.305Z. Its registry update date was 2026-04-20, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct06424106-2026-04-20-90ca90ccbc24`](#source-ctg-observation-nct06424106-2026-04-20-90ca90ccbc24))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06424106 at 2026-07-30T16:20:49.305Z. Its registry update date was 2026-04-20, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct06424106-2026-04-20-90ca90ccbc24`](#source-ctg-observation-nct06424106-2026-04-20-90ca90ccbc24))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06424106-2026-04-20-90ca90ccbc24`](#source-ctg-observation-nct06424106-2026-04-20-90ca90ccbc24))

## Sources

<a id="source-ctg-observation-nct06424106-2026-04-20-90ca90ccbc24"></a>
- **ClinicalTrials.gov record NCT06424106 · retained source version 2026-04-20:90ca90ccbc248cbdb789e0a0ab906f20a59c4d381be6b20116581832b30f45e9** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06424106) (`ctg-observation-nct06424106-2026-04-20-90ca90ccbc24`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06424106." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06424106-glucagon-v1.json SHA-256: c6dc3eaca947a3569da9725b54d4988a8fbcb1121e2f23929319e4cd0e5fa6eb.